News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
565,025 Results
Type
Article (45617)
Company Profile (121)
Press Release (519287)
Multimedia
Podcasts (81)
Webinars (11)
Section
Business (155419)
Career Advice (2410)
Deals (29038)
Drug Delivery (120)
Drug Development (71297)
Employer Resources (151)
FDA (15834)
Job Trends (12471)
News (278942)
Policy (30545)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (2)
Academia (2368)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (78)
Alliances (37005)
ALS (87)
Alzheimer's disease (1447)
Antibody-drug conjugate (ADC) (134)
Approvals (15790)
Artificial intelligence (234)
Autoimmune disease (26)
Automation (11)
Bankruptcy (318)
Best Places to Work (9663)
BIOSECURE Act (22)
Biosimilars (113)
Biotechnology (72)
Bladder cancer (66)
Brain cancer (26)
Breast cancer (258)
Cancer (2048)
Cardiovascular disease (186)
Career advice (2012)
Career pathing (32)
CAR-T (141)
Cell therapy (404)
Cervical cancer (20)
Clinical research (57886)
Collaboration (702)
Compensation (518)
Complete response letters (29)
COVID-19 (2637)
CRISPR (41)
C-suite (213)
Cystic fibrosis (97)
Data (1953)
Decentralized trials (2)
Denatured (14)
Depression (51)
Diabetes (263)
Diagnostics (5473)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (102)
Drug pricing (120)
Drug shortages (30)
Duchenne muscular dystrophy (95)
Earnings (66155)
Editorial (43)
Employer branding (20)
Employer resources (136)
Events (91410)
Executive appointments (643)
FDA (17020)
Featured Employer (33)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (636)
Gene editing (103)
Generative AI (22)
Gene therapy (304)
GLP-1 (795)
Government (4138)
Grass and pollen (5)
Guidances (47)
Healthcare (15609)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (136)
Indications (24)
Infectious disease (2781)
Inflammatory bowel disease (130)
Inflation Reduction Act (9)
Influenza (48)
Intellectual property (85)
Interviews (450)
IPO (14562)
IRA (48)
Job creations (3199)
Job search strategy (1672)
Kidney cancer (10)
Labor market (30)
Layoffs (506)
Leadership (21)
Legal (7184)
Liver cancer (70)
Lung cancer (296)
Lymphoma (141)
Machine learning (5)
Management (51)
Manufacturing (283)
MASH (67)
Medical device (11575)
Medtech (11578)
Mergers & acquisitions (14971)
Metabolic disorders (718)
Multiple sclerosis (76)
NASH (22)
Neurodegenerative disease (95)
Neuropsychiatric disorders (32)
Neuroscience (1969)
NextGen: Class of 2025 (5206)
Non-profit (3371)
Northern California (2419)
Now hiring (17)
Obesity (401)
Opinion (223)
Ovarian cancer (67)
Pain (83)
Pancreatic cancer (75)
Parkinson's disease (147)
Partnered (16)
Patents (225)
Patient recruitment (94)
Peanut (45)
People (44199)
Pharmaceutical (36)
Pharmacy benefit managers (21)
Phase I (17170)
Phase II (25157)
Phase III (20502)
Pipeline (1120)
Policy (160)
Postmarket research (2377)
Preclinical (7075)
Press Release (37)
Prostate cancer (101)
Psychedelics (36)
Radiopharmaceuticals (221)
Rare diseases (393)
Real estate (4408)
Recruiting (60)
Regulatory (21349)
Reports (32)
Research institute (2100)
Resumes & cover letters (402)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (74)
Series A (119)
Series B (77)
Service/supplier (10)
Sickle cell disease (54)
Southern California (2050)
Special edition (16)
Spinal muscular atrophy (132)
Sponsored (32)
Startups (2821)
State (1)
Stomach cancer (16)
Supply chain (71)
Tariffs (33)
The Weekly (66)
United States (20428)
Vaccines (752)
Venture capitalists (42)
Weight loss (293)
Women's health (31)
Worklife (19)
Date
Today (123)
Last 7 days (447)
Last 30 days (2327)
Last 365 days (30568)
2025 (9138)
2024 (32375)
2023 (36368)
2022 (46522)
2021 (50211)
2020 (47197)
2019 (38130)
2018 (28868)
2017 (28819)
2016 (27348)
2015 (30613)
2014 (24117)
2013 (19575)
2012 (21042)
2011 (21514)
2010 (19459)
Location
Africa (683)
Alabama (46)
Alaska (6)
Arizona (177)
Arkansas (10)
Asia (32370)
Australia (5663)
California (5439)
Canada (1558)
China (415)
Colorado (235)
Connecticut (262)
Delaware (126)
Europe (78467)
Florida (813)
Georgia (185)
Hawaii (1)
Idaho (39)
Illinois (445)
India (23)
Indiana (257)
Iowa (10)
Japan (144)
Kansas (83)
Kentucky (13)
Louisiana (6)
Maine (62)
Maryland (828)
Massachusetts (4105)
Michigan (185)
Minnesota (335)
Mississippi (1)
Missouri (72)
Montana (12)
Nebraska (19)
Nevada (54)
New Hampshire (52)
New Jersey (1568)
New Mexico (15)
New York (1538)
North Carolina (902)
North Dakota (6)
Northern California (2419)
Ohio (157)
Oklahoma (8)
Oregon (28)
Pennsylvania (1184)
Puerto Rico (10)
Rhode Island (20)
South America (1049)
South Carolina (19)
South Dakota (1)
Southern California (2050)
Tennessee (86)
Texas (766)
Utah (153)
Virginia (128)
Washington D.C. (59)
Washington State (504)
West Virginia (3)
Wisconsin (50)
565,025 Results for "chiesi farmaceutici s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
Gossamer Bio, Inc. and Chiesi Farmaceutici S.p.A announced that they have entered into a global collaboration and license agreement to develop and commercialize seralutinib.
May 6, 2024
·
9 min read
Deals
Chiesi Farmaceutici S.p.A. Completes Acquisition of Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. announced the completion of the acquisition of Amryt Pharma Plc, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing, and commercializing novel treatments for rare diseases.
April 12, 2023
·
3 min read
Bio NC
Chiesi to Present New Data Showcasing Depth of Respiratory Leadership at the American Thoracic Society 2024 International Conference
Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced the presentation of eight abstracts from Chiesi’s global respiratory research portfolio at the American Thoracic Society (ATS) 2024 International Conference in San Diego from May 17-22, 2024.
May 16, 2024
·
6 min read
Deals
Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc
Chiesi Farmaceutici S.p.A. and Amryt Pharma Plc announced that the companies have entered into a definitive agreement under which Chiesi will acquire Amryt.
January 8, 2023
·
12 min read
Deals
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici
Amryt Pharma Shareholders approve acquisition of Amryt Pharma by Chiesi Farmaceutici.
March 22, 2023
·
6 min read
Business
Nemysis Limited Announces a Strategic Alliance With Bruno Farmaceutici S.p.A.
Nemysis is pleased to announce that it has entered into a Strategic Alliance Agreement with Bruno Farmaceutici S.p.A. for the mutual advancement of the portfolio and sales of each company.
November 8, 2023
·
2 min read
Business
Chiesi USA Appoints Richard Smith as Vice President and Business Unit Leader, U.S. AIR
Chiesi USA, Inc. today announced it has appointed Richard Smith as vice president and business unit leader of U.S. AIR.
April 15, 2024
·
4 min read
Chiesi Group signed a License Agreement with Haisco Pharmaceutical to develop, manufacture, and commercialise a novel, reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis
Chiesi Farmaceutici S.p.A and Haisco Pharmaceutical Group Co.Ltd announced the execution of a Licensing Agreement to develop, manufacture, and commercialise outside China and adjacent territories HSK31858, a novel, reversible dipeptidyl peptidase 1 inhibitor for respiratory diseases.
November 20, 2023
·
2 min read
Genetown
Chiesi Global Rare Diseases Showcases Ongoing Commitment to Multiple Rare Diseases Communities at ENDO 2024 Meeting Debut
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, announced updates from their rare endocrine disease portfolio with two late-breaking poster presentations and one oral presentation during the Endocrine Society’s ENDO 2024 Meeting that was held June 1-4, 2024, in Boston, Massachusetts.
June 14, 2024
·
9 min read
Genetown
Chiesi Global Rare Diseases Makes Debut in the Endocrinology Landscape with Multiple Presentations at the Endocrine Society’s ENDO 2024 Meeting
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced that three abstracts have been accepted for presentation at the Endocrine Society’s ENDO 2024 Meeting to be held June 1-4, 2024, in Boston, Massachusetts.
May 22, 2024
·
5 min read
1 of 56,503
Next
